CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
G
Aatk
apoptosis-associated tyrosine kinase
increases expression
ISO
ferric oxide analog results in increased expression of AATK mRNA
CTD
PMID:25086211
NCBI chr10:109,184,338...109,224,455
Ensembl chr10:109,188,112...109,224,370
G
Ache
acetylcholinesterase
decreases activity
ISO
ferric oxide results in decreased activity of ACHE protein
CTD
PMID:28993115
NCBI chr12:22,472,358...22,477,052
Ensembl chr12:22,472,358...22,478,753
G
Acss2
acyl-CoA synthetase short-chain family member 2
increases expression
ISO
ferric oxide analog results in increased expression of ACSS2 mRNA
CTD
PMID:25086211
NCBI chr 3:151,032,925...151,075,856
Ensembl chr 3:151,032,952...151,075,856
G
Adgre1
adhesion G protein-coupled receptor E1
increases expression
ISO
ferric oxide analog results in increased expression of ADGRE1 mRNA
CTD
PMID:24525745
NCBI chr 9:9,431,888...9,585,883
Ensembl chr 9:9,431,860...9,585,865
G
Adm
adrenomedullin
increases expression
ISO
ferric oxide analog results in increased expression of ADM mRNA
CTD
PMID:25086211
NCBI chr 1:175,443,189...175,447,260
Ensembl chr 1:175,445,088...175,447,259
G
Adora2b
adenosine A2B receptor
increases expression
ISO
ferric oxide analog results in increased expression of ADORA2B mRNA
CTD
PMID:25086211
NCBI chr10:48,569,563...48,586,366
Ensembl chr10:48,569,555...48,586,365
G
Ahnak2
AHNAK nucleoprotein 2
increases expression
ISO
ferric oxide analog results in increased expression of AHNAK2 mRNA
CTD
PMID:25086211
NCBI chr 6:137,335,273...137,380,219
G
Ahrr
aryl-hydrocarbon receptor repressor
increases expression
ISO
ferric oxide analog results in increased expression of AHRR mRNA
CTD
PMID:24525745
NCBI chr 1:31,603,297...31,698,329
Ensembl chr 1:31,603,297...31,698,329
G
Aig1
androgen-induced 1
increases expression
ISO
ferric oxide analog results in increased expression of AIG1 mRNA
CTD
PMID:25086211
NCBI chr 1:7,816,841...8,038,805
Ensembl chr 1:7,816,838...8,038,665
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
EXP
[ferric oxide analog co-treated with Acrolein] results in increased phosphorylation of AKT1 protein
CTD
PMID:24847785
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
G
Aldh1l2
aldehyde dehydrogenase 1 family, member L2
decreases expression
ISO
ferric oxide analog results in decreased expression of ALDH1L2 mRNA
CTD
PMID:25086211
NCBI chr 7:26,375,866...26,425,838
Ensembl chr 7:26,375,866...26,425,108
G
Ankrd12
ankyrin repeat domain 12
decreases expression
ISO
ferric oxide analog results in decreased expression of ANKRD12 mRNA
CTD
PMID:24525745
NCBI chr 9:113,605,683...113,682,482
Ensembl chr 9:113,605,657...113,682,482
G
Anln
anillin, actin binding protein
decreases expression increases expression
ISO
ferric oxide analog results in decreased expression of ANLN mRNA ferric oxide analog results in increased expression of ANLN mRNA
CTD
PMID:24525745 PMID:25086211
NCBI chr 8:23,336,455...23,397,122
Ensembl chr 8:23,337,621...23,390,773
G
Anxa3
annexin A3
decreases expression
ISO
ferric oxide analog results in decreased expression of ANXA3 mRNA
CTD
PMID:25086211
NCBI chr14:14,371,921...14,426,503
Ensembl chr14:14,364,008...14,426,437
G
Ap5b1
adaptor related protein complex 5 subunit beta 1
decreases expression
ISO
ferric oxide analog results in decreased expression of AP5B1 mRNA
CTD
PMID:25086211
NCBI chr 1:220,948,318...220,952,349
Ensembl chr 1:220,948,331...220,952,391
G
Arhgap24
Rho GTPase activating protein 24
increases expression
ISO
ferric oxide analog results in increased expression of ARHGAP24 mRNA
CTD
PMID:25086211
NCBI chr14:8,383,211...8,600,526
Ensembl chr14:8,383,214...8,600,512
G
Atf3
activating transcription factor 3
increases expression
ISO
ferric oxide analog results in increased expression of ATF3 protein
CTD
PMID:24068039
NCBI chr13:109,817,892...109,849,632
Ensembl chr13:109,817,728...109,849,632
G
Atg5
autophagy related 5
increases expression
ISO
ferric oxide analog results in increased expression of ATG5 protein
CTD
PMID:24068039
NCBI chr20:49,301,783...49,393,147
Ensembl chr20:49,318,308...49,393,140
G
B3galnt1
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)
increases expression
ISO
ferric oxide analog results in increased expression of B3GALNT1 mRNA
CTD
PMID:24525745
NCBI chr 2:166,226,736...166,255,978
Ensembl chr 2:166,226,754...166,255,302
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression decreases expression increases phosphorylation
ISO EXP
bromotetrandrine promotes the reaction [[ferric oxide co-treated with ferrous oxide co-treated with Daunorubicin] results in increased expression of BAX protein] ferric oxide results in increased expression of BAX protein ferric oxide results in decreased expression of BAX protein ferric oxide analog results in increased phosphorylation of BAX protein
CTD
PMID:19421372 PMID:22995439 PMID:25086211 PMID:26991130
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
G
Bcl2
BCL2, apoptosis regulator
increases phosphorylation increases expression
EXP ISO
ferric oxide analog results in increased phosphorylation of BCL2 protein ferric oxide analog results in increased expression of BCL2 protein
CTD
PMID:22995439 PMID:25086211
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
G
Bcl2l11
BCL2 like 11
increases expression
ISO
ferric oxide analog results in increased expression of BCL2L11 mRNA; ferric oxide analog results in increased expression of BCL2L11 protein
CTD
PMID:24525745 PMID:25086211
NCBI chr 3:120,726,906...120,764,192
Ensembl chr 3:120,726,906...120,764,192
G
Bdh2
3-hydroxybutyrate dehydrogenase 2
increases expression
ISO
ferric oxide analog results in increased expression of BDH2 mRNA
CTD
PMID:25086211
NCBI chr 2:240,461,505...240,482,149
Ensembl chr 2:240,461,505...240,482,145
G
Becn1
beclin 1
decreases expression increases expression
ISO
ferric oxide results in decreased expression of BECN1 protein ferric oxide analog results in increased expression of BECN1 protein
CTD
PMID:24068039 PMID:25086211
NCBI chr10:89,209,944...89,225,297
Ensembl chr10:89,209,940...89,225,297
G
Bhlhe40
basic helix-loop-helix family, member e40
increases expression
ISO
ferric oxide analog results in increased expression of BHLHE40 mRNA
CTD
PMID:25086211
NCBI chr 4:140,703,619...140,709,319
Ensembl chr 4:140,703,619...140,709,319
G
Canx
calnexin
decreases expression
ISO
ferric oxide results in decreased expression of CANX protein
CTD
PMID:25086211
NCBI chr10:35,800,942...35,833,939
Ensembl chr10:35,800,942...35,833,861
G
Casp3
caspase 3
multiple interactions increases cleavage
ISO
bromotetrandrine promotes the reaction [[ferric oxide co-treated with ferrous oxide co-treated with Daunorubicin] results in increased expression of CASP3 protein] ferric oxide results in increased cleavage of CASP3 protein
CTD
PMID:19421372 PMID:26991130
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
G
Castor1
cytosolic arginine sensor for mTORC1 subunit 1
increases expression
ISO
ferric oxide analog results in increased expression of CASTOR1 mRNA
CTD
PMID:25086211
NCBI chr14:84,447,552...84,457,396
Ensembl chr14:84,447,885...84,452,367
G
Cat
catalase
decreases activity decreases expression
ISO
ferric oxide results in decreased activity of CAT protein ferric oxide results in decreased expression of CAT protein
CTD
PMID:19699289 PMID:26991130 PMID:28993115
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
G
Ccdc85b
coiled-coil domain containing 85B
increases expression
ISO
ferric oxide analog results in increased expression of CCDC85B mRNA
CTD
PMID:25086211
NCBI chr 1:220,835,647...220,837,220
G
Ccl2
C-C motif chemokine ligand 2
increases secretion
ISO
ferric oxide results in increased secretion of CCL2 protein
CTD
PMID:24885771
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
G
Ccl22
C-C motif chemokine ligand 22
increases secretion
ISO
ferric oxide results in increased secretion of CCL22 protein
CTD
PMID:24885771
NCBI chr19:10,674,189...10,681,145
Ensembl chr19:10,674,189...10,681,145
G
Ccl3
C-C motif chemokine ligand 3
increases secretion
ISO
ferric oxide results in increased secretion of CCL3 protein
CTD
PMID:24885771
NCBI chr10:70,869,516...70,871,066
Ensembl chr10:70,869,513...70,871,066
G
Ccl4
C-C motif chemokine ligand 4
decreases expression increases secretion
ISO
ferric oxide analog results in decreased expression of CCL4 mRNA ferric oxide results in increased secretion of CCL4 protein
CTD
PMID:24525745 PMID:24885771
NCBI chr10:70,870,926...70,886,357
Ensembl chr10:70,884,531...70,886,355
G
Ccl7
C-C motif chemokine ligand 7
increases secretion
ISO
ferric oxide results in increased secretion of CCL7 protein
CTD
PMID:24885771
NCBI chr10:69,423,083...69,424,933
Ensembl chr10:69,423,086...69,424,979
G
Cd14
CD14 molecule
decreases expression
ISO
ferric oxide analog results in decreased expression of CD14 mRNA
CTD
PMID:25086211
NCBI chr18:29,560,341...29,562,290
Ensembl chr18:29,560,365...29,562,153
G
Cd274
CD274 molecule
increases expression
ISO
ferric oxide analog results in increased expression of CD274 mRNA
CTD
PMID:25086211
NCBI chr 1:247,519,890...247,539,659
Ensembl chr 1:247,519,939...247,537,943
G
Cd74
CD74 molecule
decreases expression
ISO
ferric oxide analog results in decreased expression of CD74 mRNA
CTD
PMID:25086211
NCBI chr18:56,071,420...56,080,851
Ensembl chr18:56,071,478...56,080,849
G
Cd83
CD83 molecule
increases expression
ISO
ferric oxide analog results in increased expression of CD83 mRNA
CTD
PMID:24525745 PMID:25086211
NCBI chr17:24,416,651...24,435,790
Ensembl chr17:24,416,651...24,435,790
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
EXP
ferric oxide analog results in increased expression of CDKN1A protein
CTD
PMID:22995439
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
multiple interactions
EXP
[ferric oxide analog co-treated with Acrolein] results in decreased expression of CDKN1B protein
CTD
PMID:24847785
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
decreases expression
ISO
ferric oxide analog results in decreased expression of CDKN2A mRNA
CTD
PMID:24525745
NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
G
Cep83
centrosomal protein 83
decreases expression
ISO
ferric oxide analog results in decreased expression of CEP83 mRNA
CTD
PMID:24525745
NCBI chr 7:35,739,553...35,847,618
Ensembl chr 7:35,773,928...35,847,617
G
Clec5a
C-type lectin domain containing 5A
decreases expression
ISO
ferric oxide analog results in decreased expression of CLEC5A mRNA
CTD
PMID:25086211
NCBI chr 4:68,810,330...68,819,921
Ensembl chr 4:68,808,359...68,819,928
G
Clk4
CDC-like kinase 4
increases expression
ISO
ferric oxide analog results in increased expression of CLK4 mRNA
CTD
PMID:25086211
NCBI chr10:36,715,565...36,733,473
Ensembl chr10:36,715,565...36,733,133
G
Cox6a2
cytochrome c oxidase subunit 6A2
decreases expression
ISO
ferric oxide analog results in decreased expression of COX6A2 mRNA
CTD
PMID:25086211
NCBI chr 1:199,624,037...199,626,255
Ensembl chr 1:199,624,037...199,624,783
G
Csnk1e
casein kinase 1, epsilon
increases expression
ISO
ferric oxide analog results in increased expression of CSNK1E mRNA
CTD
PMID:25086211
NCBI chr 7:120,651,976...120,675,559
Ensembl chr 7:120,651,881...120,672,359
G
Cx3cr1
C-X3-C motif chemokine receptor 1
decreases expression
ISO
ferric oxide analog results in decreased expression of CX3CR1 mRNA
CTD
PMID:25086211
NCBI chr 8:128,740,756...128,754,514
Ensembl chr 8:128,740,756...128,754,514
G
Cxcr4
C-X-C motif chemokine receptor 4
increases expression
ISO
ferric oxide analog results in increased expression of CXCR4 mRNA
CTD
PMID:25086211
NCBI chr13:45,314,952...45,318,856
Ensembl chr13:45,314,933...45,318,878
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
EXP
ferric oxide promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A1 protein]; ferric oxide promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]
CTD
PMID:15211619
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
G
Ddit3
DNA-damage inducible transcript 3
increases expression decreases expression
ISO
ferric oxide analog results in increased expression of DDIT3 mRNA; ferric oxide analog results in increased expression of DDIT3 protein ferric oxide analog results in decreased expression of DDIT3 mRNA
CTD
PMID:24525745 PMID:25086211
NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
G
Ddit4
DNA-damage-inducible transcript 4
decreases expression
ISO
ferric oxide analog results in decreased expression of DDIT4 mRNA
CTD
PMID:24525745
NCBI chr20:29,509,283...29,511,382
Ensembl chr20:29,509,289...29,511,382
G
Dgkg
diacylglycerol kinase, gamma
decreases expression
ISO
ferric oxide analog results in decreased expression of DGKG mRNA
CTD
PMID:25086211
NCBI chr11:81,971,585...82,165,111
Ensembl chr11:81,972,219...82,163,165
G
Dusp1
dual specificity phosphatase 1
decreases expression
ISO
ferric oxide analog results in decreased expression of DUSP1 mRNA
CTD
PMID:25086211
NCBI chr10:16,970,642...16,973,425
Ensembl chr10:16,970,626...16,973,418
G
Dusp4
dual specificity phosphatase 4
increases expression
ISO
ferric oxide analog results in increased expression of DUSP4 mRNA
CTD
PMID:25086211
NCBI chr16:61,080,767...61,090,973
Ensembl chr16:61,078,175...61,091,169
G
Eef1a1
eukaryotic translation elongation factor 1 alpha 1
decreases expression
ISO
ferric oxide analog results in decreased expression of EEF1A1 mRNA
CTD
PMID:25086211
NCBI chr 8:85,838,594...85,841,816
Ensembl chr 8:85,838,869...85,840,818
G
Egfr
epidermal growth factor receptor
increases phosphorylation
ISO
ferric oxide analog results in increased phosphorylation of EGFR protein
CTD
PMID:24068039
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
G
Egr1
early growth response 1
decreases expression
ISO
ferric oxide analog results in decreased expression of EGR1 mRNA
CTD
PMID:25086211
NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
G
Egr2
early growth response 2
increases expression
ISO
ferric oxide analog results in increased expression of EGR2 mRNA
CTD
PMID:24525745 PMID:25086211
NCBI chr20:22,452,170...22,461,018
Ensembl chr20:22,454,463...22,459,025
G
Eif2ak2
eukaryotic translation initiation factor 2-alpha kinase 2
decreases expression
ISO
ferric oxide analog results in decreased expression of EIF2AK2 mRNA
CTD
PMID:25086211
NCBI chr 6:1,428,845...1,466,193
Ensembl chr 6:1,428,834...1,466,201
G
Eno2
enolase 2
increases expression decreases expression
ISO
ferric oxide analog results in increased expression of ENO2 mRNA ferric oxide analog results in decreased expression of ENO2 mRNA
CTD
PMID:24525745 PMID:25086211
NCBI chr 4:157,285,192...157,294,090
Ensembl chr 4:157,285,179...157,294,047
G
Epn2
epsin 2
increases expression
ISO
ferric oxide analog results in increased expression of EPN2 mRNA
CTD
PMID:25086211
NCBI chr10:47,795,496...47,857,373
Ensembl chr10:47,795,524...47,857,326
G
Ern1
endoplasmic reticulum to nucleus signaling 1
multiple interactions
ISO
ferric oxide analog results in increased expression of and results in increased phosphorylation of ERN1 protein
CTD
PMID:25086211
NCBI chr10:94,588,555...94,682,072
Ensembl chr10:94,588,555...94,681,914
G
Fam214a
family with sequence similarity 214, member A
increases expression
ISO
ferric oxide analog results in increased expression of FAM214A mRNA
CTD
PMID:25086211
NCBI chr 8:81,863,619...81,941,548
Ensembl chr 8:81,863,619...81,941,536
G
Fblim1
filamin binding LIM protein 1
increases expression
ISO
ferric oxide analog results in increased expression of FBLIM1 mRNA
CTD
PMID:25086211
NCBI chr 5:160,122,466...160,158,921
Ensembl chr 5:160,122,425...160,158,386
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression increases expression
ISO
ferric oxide analog results in decreased expression of FOS mRNA ferric oxide analog results in increased expression of FOS mRNA
CTD
PMID:24525745 PMID:25086211
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
G
Fus
FUS RNA binding protein
decreases expression
ISO
ferric oxide analog results in decreased expression of FUS mRNA
CTD
PMID:25086211
NCBI chr 1:199,412,805...199,426,705
Ensembl chr 1:199,412,834...199,426,702
G
Fyb1
FYN binding protein 1
decreases expression
ISO
ferric oxide analog results in decreased expression of FYB mRNA
CTD
PMID:25086211
NCBI chr 2:55,834,904...55,983,805
Ensembl chr 2:55,835,151...55,983,804
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases phosphorylation
EXP
ferric oxide analog results in increased phosphorylation of GADD45A protein
CTD
PMID:22995439
NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
increases expression
ISO
ferric oxide analog results in increased expression of GADD45B mRNA
CTD
PMID:25086211
NCBI chr 7:11,646,283...11,648,338
Ensembl chr 7:11,646,269...11,648,322
G
Gja1
gap junction protein, alpha 1
increases expression
ISO
ferric oxide analog results in increased expression of GJA1 mRNA
CTD
PMID:25086211
NCBI chr20:37,876,650...37,889,097
Ensembl chr20:37,876,650...37,889,089
G
Gpr183
G protein-coupled receptor 183
increases expression
ISO
ferric oxide analog results in increased expression of GPR183 mRNA
CTD
PMID:24525745
NCBI chr15:108,364,701...108,376,221
Ensembl chr15:108,364,701...108,376,221
G
Gpr84
G protein-coupled receptor 84
decreases expression increases expression
ISO
ferric oxide analog results in decreased expression of GPR84 mRNA ferric oxide analog results in increased expression of GPR84 mRNA
CTD
PMID:24525745 PMID:25086211
NCBI chr 7:144,934,606...144,937,194
Ensembl chr 7:144,934,610...144,936,803
G
Gsr
glutathione-disulfide reductase
multiple interactions
ISO
[Benzo(a)pyrene co-treated with ferric oxide] results in increased activity of GSR protein
CTD
PMID:11033230
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
G
H2ax
H2A.X variant histone
multiple interactions increases expression
ISO
Oxygen deficiency inhibits the reaction [ferric oxide analog results in increased expression of H2AX protein]
CTD
PMID:27270449
NCBI chr 8:48,665,652...48,666,981
Ensembl chr 8:48,665,652...48,666,981
G
H2bc9
H2B clustered histone 9
decreases expression
ISO
ferric oxide analog results in decreased expression of H2BC9 mRNA
CTD
PMID:24525745 PMID:25086211
NCBI chr17:44,519,815...44,520,269
Ensembl chr17:44,519,860...44,520,240
G
H3c1
H3 clustered histone 1
decreases expression
ISO
ferric oxide analog results in decreased expression of H3C1 mRNA
CTD
PMID:25086211
NCBI chr17:43,616,206...43,616,735
Ensembl chr17:44,839,721...44,840,131 Ensembl chr17:44,839,721...44,840,131 Ensembl chr17:44,839,721...44,840,131 Ensembl chr17:44,839,721...44,840,131
G
Hbegf
heparin-binding EGF-like growth factor
increases expression
ISO
ferric oxide analog results in increased expression of HBEGF mRNA
CTD
PMID:25086211
NCBI chr18:29,330,302...29,340,185
Ensembl chr18:29,329,764...29,340,403
G
Heatr3
HEAT repeat containing 3
decreases expression
ISO
ferric oxide analog results in decreased expression of HEATR3 mRNA
CTD
PMID:25086211
NCBI chr19:19,858,419...19,896,782
Ensembl chr19:19,858,416...19,896,421
G
Hebp1
heme binding protein 1
increases expression
ISO
ferric oxide analog results in increased expression of HEBP1 mRNA
CTD
PMID:25086211
NCBI chr 4:168,903,586...168,933,102
Ensembl chr 4:168,903,565...168,933,079
G
Hilpda
hypoxia inducible lipid droplet-associated
increases expression
ISO
ferric oxide analog results in increased expression of HILPDA mRNA
CTD
PMID:25086211
NCBI chr 4:56,547,600...56,550,584
Ensembl chr 4:56,549,739...56,549,993
G
Hist1h2ail1
histone cluster 1 H2a family member I like 1
decreases expression
ISO
ferric oxide analog results in decreased expression of H3C6 mRNA
CTD
PMID:25086211
NCBI chr17:43,814,773...43,815,183
Ensembl chr17:43,814,773...43,815,183 Ensembl chr17:43,814,773...43,815,183
G
Hist1h2bq
histone cluster 1 H2B family member Q
decreases expression
ISO
ferric oxide analog results in decreased expression of H2BC7 mRNA
CTD
PMID:24525745 PMID:25086211
NCBI chr17:43,679,925...43,689,311
Ensembl chr17:43,679,925...43,689,311
G
Hist2h2be
histone cluster 2 H2B family member E
decreases expression increases expression
ISO
ferric oxide analog results in decreased expression of H2BC11 mRNA ferric oxide analog results in increased expression of H2BC21 mRNA
CTD
PMID:25086211
NCBI chr 2:198,360,837...198,363,399
Ensembl chr 2:198,360,998...198,361,378
G
Hmox1
heme oxygenase 1
increases expression
ISO
ferric oxide analog results in increased expression of HMOX1 mRNA
CTD
PMID:24525745 PMID:25086211
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
G
Hsd3b7
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7
increases expression
ISO
ferric oxide analog results in increased expression of HSD3B7 mRNA
CTD
PMID:25086211
NCBI chr 1:199,248,084...199,251,745
Ensembl chr 1:199,248,470...199,251,740
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with ferric oxide] results in increased expression of HSPA1A mRNA
CTD
PMID:20540983
NCBI chr20:4,875,834...4,881,751
Ensembl chr20:4,877,324...4,879,779
G
Hspa8
heat shock protein family A (Hsp70) member 8
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with ferric oxide] results in increased expression of HSPA8 mRNA
CTD
PMID:20540983
NCBI chr 8:44,989,401...44,993,261
Ensembl chr 8:44,990,014...44,993,179
G
Hspd1
heat shock protein family D (Hsp60) member 1
decreases expression
ISO
ferric oxide results in decreased expression of HSPD1 protein
CTD
PMID:28077287
NCBI chr 9:61,680,529...61,691,202
Ensembl chr 9:61,680,530...61,690,956
G
Hyal1
hyaluronidase 1
increases expression decreases expression
ISO
ferric oxide analog results in increased expression of HYAL1 mRNA ferric oxide analog results in decreased expression of HYAL1 mRNA
CTD
PMID:24525745 PMID:25086211
NCBI chr 8:116,332,834...116,337,522
Ensembl chr 8:116,332,796...116,335,435
G
Icam1
intercellular adhesion molecule 1
increases expression
ISO
ferric oxide results in increased expression of ICAM1 protein
CTD
PMID:21439359
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
G
Icam2
intercellular adhesion molecule 2
decreases expression
ISO
ferric oxide analog results in decreased expression of ICAM2 mRNA
CTD
PMID:25086211
NCBI chr10:94,569,889...94,581,218
Ensembl chr10:94,569,890...94,576,512
G
Id1
inhibitor of DNA binding 1, HLH protein
increases expression
ISO
ferric oxide analog results in increased expression of ID1 mRNA
CTD
PMID:24525745
NCBI chr 3:148,214,623...148,216,715
Ensembl chr 3:148,215,540...148,216,718
G
Id3
inhibitor of DNA binding 3, HLH protein
increases expression
ISO
ferric oxide analog results in increased expression of ID3 mRNA
CTD
PMID:24525745
NCBI chr 5:154,489,603...154,491,172
Ensembl chr 5:154,489,590...154,491,223
G
Il10ra
interleukin 10 receptor subunit alpha
decreases expression
ISO
ferric oxide analog results in decreased expression of IL10RA mRNA
CTD
PMID:25086211
NCBI chr 8:49,558,062...49,573,891
Ensembl chr 8:49,560,035...49,573,742
G
Il1b
interleukin 1 beta
increases secretion
ISO
ferric oxide analog results in increased secretion of IL1B protein ferric oxide results in increased secretion of IL1B protein
CTD
PMID:24525745 PMID:24885771
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
G
Il2
interleukin 2
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with ferric oxide] results in increased expression of IL2 protein
CTD
PMID:20540983
NCBI chr 2:123,847,150...123,851,854
Ensembl chr 2:123,847,150...123,851,854
G
Il4
interleukin 4
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with ferric oxide] results in increased expression of IL4 protein; ferric oxide inhibits the reaction [Ovalbumin results in increased expression of IL4 protein]
CTD
PMID:20540983 PMID:23147377
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
G
Il5
interleukin 5
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with ferric oxide] results in increased expression of IL5 protein
CTD
PMID:20540983
NCBI chr10:39,066,716...39,069,587
Ensembl chr10:39,066,716...39,069,587
G
Il6
interleukin 6
multiple interactions increases secretion
ISO
[Magnetite Nanoparticles co-treated with ferric oxide] results in increased expression of IL6 protein ferric oxide results in increased secretion of IL6 protein ferric oxide analog results in increased secretion of IL6 protein
CTD
PMID:20540983 PMID:24525745 PMID:24885771
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
G
Irf7
interferon regulatory factor 7
decreases expression
ISO
ferric oxide analog results in decreased expression of IRF7 mRNA
CTD
PMID:25086211
NCBI chr 1:214,249,388...214,252,909
Ensembl chr 1:214,248,837...214,252,456
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases phosphorylation
EXP
ferric oxide analog results in increased phosphorylation of JUN protein
CTD
PMID:22995439
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
G
Klf2
Kruppel-like factor 2
decreases expression
ISO
ferric oxide analog results in decreased expression of KLF2 mRNA
CTD
PMID:25086211
NCBI chr16:19,223,087...19,225,037
Ensembl chr16:19,223,087...19,225,037
G
Klf4
Kruppel like factor 4
decreases expression
ISO
ferric oxide analog results in decreased expression of KLF4 mRNA
CTD
PMID:25086211
NCBI chr 5:72,283,311...72,287,669
Ensembl chr 5:72,283,313...72,287,669
G
Lamp1
lysosomal-associated membrane protein 1
multiple interactions
EXP
[ferric oxide analog co-treated with Acrolein] results in decreased expression of LAMP1 protein
CTD
PMID:24847785
NCBI chr16:81,689,576...81,714,341
Ensembl chr16:81,689,335...81,714,419
G
Lamp2
lysosomal-associated membrane protein 2
increases expression
ISO
ferric oxide analog results in increased expression of LAMP2 protein
CTD
PMID:25086211
NCBI chr X:124,722,628...124,766,079
Ensembl chr X:124,722,628...124,766,044
G
Lilrb4
leukocyte immunoglobulin like receptor B4
decreases expression
ISO
ferric oxide analog results in decreased expression of LILR4B mRNA
CTD
PMID:24525745
NCBI chr 1:73,393,854...73,399,448
Ensembl chr 1:73,393,850...73,399,579
G
Lima1
LIM domain and actin binding 1
increases expression
ISO
ferric oxide analog results in increased expression of LIMA1 mRNA
CTD
PMID:25086211
NCBI chr 7:141,428,113...141,528,447
Ensembl chr 7:141,428,063...141,528,397
G
Lims2
LIM zinc finger domain containing 2
increases expression
ISO
ferric oxide analog results in increased expression of LIMS2 mRNA
CTD
PMID:25086211
NCBI chr18:24,707,951...24,746,159
Ensembl chr18:24,708,115...24,746,159
G
Lst1
leukocyte specific transcript 1
decreases expression
ISO
ferric oxide analog results in decreased expression of LST1 mRNA
CTD
PMID:24525745
NCBI chr20:5,175,213...5,179,352
Ensembl chr20:5,176,016...5,179,263
G
Lyz2
lysozyme 2
decreases expression
ISO
ferric oxide analog results in decreased expression of LYZ2 mRNA
CTD
PMID:25086211
NCBI chr 7:60,335,968...60,341,264
Ensembl chr 7:60,335,969...60,341,264
G
Mafb
MAF bZIP transcription factor B
increases expression
ISO
ferric oxide analog results in increased expression of MAFB mRNA
CTD
PMID:24525745
NCBI chr 3:156,338,993...156,340,913
Ensembl chr 3:156,339,004...156,340,913
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
increases expression
ISO
ferric oxide analog results in increased expression of MAP1LC3A protein
CTD
PMID:25086211
NCBI chr 3:150,801,289...150,802,935
Ensembl chr 3:150,801,289...150,802,935
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
increases expression
ISO
ferric oxide analog results in increased expression of MAP1LC3B protein
CTD
PMID:24068039
NCBI chr19:53,635,449...53,643,970
Ensembl chr19:53,629,779...53,646,058
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation multiple interactions
ISO EXP
ferric oxide analog results in increased phosphorylation of MAPK1 protein [ferric oxide analog co-treated with Acrolein] results in increased phosphorylation of MAPK1 protein
CTD
PMID:24068039 PMID:24847785
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation multiple interactions
ISO EXP
ferric oxide analog results in increased phosphorylation of MAPK3 protein [ferric oxide analog co-treated with Acrolein] results in increased phosphorylation of MAPK3 protein
CTD
PMID:24068039 PMID:24847785
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
G
Mat2a
methionine adenosyltransferase 2A
decreases expression increases expression
ISO
ferric oxide analog results in decreased expression of MAT2A mRNA ferric oxide analog results in increased expression of MAT2A mRNA
CTD
PMID:24525745 PMID:25086211
NCBI chr 4:100,297,478...100,303,047
Ensembl chr 4:100,296,075...100,303,080
G
Mef2c
myocyte enhancer factor 2C
decreases expression
ISO
ferric oxide analog results in decreased expression of MEF2C mRNA
CTD
PMID:25086211
NCBI chr 2:11,658,534...11,822,788
Ensembl chr 2:11,658,568...11,822,787
G
Mmp12
matrix metallopeptidase 12
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with ferric oxide] results in increased expression of MMP12 mRNA
CTD
PMID:20540983
NCBI chr 8:5,594,717...5,616,494
Ensembl chr 8:5,606,592...5,616,493
G
Mmp19
matrix metallopeptidase 19
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with ferric oxide] results in increased expression of MMP19 mRNA
CTD
PMID:20540983
NCBI chr 7:3,216,392...3,224,202
Ensembl chr 7:3,216,497...3,224,201
G
Mmp2
matrix metallopeptidase 2
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with ferric oxide] results in increased expression of MMP2 mRNA
CTD
PMID:20540983
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
G
Mmp23
matrix metallopeptidase 23
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with ferric oxide] results in increased expression of MMP23 mRNA
CTD
PMID:20540983
NCBI chr 5:173,078,811...173,082,834
Ensembl chr 5:173,078,590...173,081,839
G
Mmp7
matrix metallopeptidase 7
increases expression
ISO
ferric oxide results in increased expression of MMP7 protein
CTD
PMID:24885771
NCBI chr 8:5,893,253...5,900,965
Ensembl chr 8:5,893,249...5,901,049
G
Msmb
microseminoprotein, beta
affects expression
ISO
ferric oxide affects the expression of MSMB mRNA
CTD
PMID:28077287
NCBI chr16:8,280,275...8,300,853
Ensembl chr16:8,280,275...8,300,852
G
Naa80
N(alpha)-acetyltransferase 80, NatH catalytic subunit
increases expression
ISO
ferric oxide analog results in increased expression of NAA80 mRNA
CTD
PMID:25086211
NCBI chr 8:116,336,441...116,339,691
Ensembl chr 8:116,336,441...116,339,690
G
Nckap5l
NCK-associated protein 5-like
decreases expression
ISO
ferric oxide analog results in decreased expression of NCKAP5L mRNA
CTD
PMID:24525745
NCBI chr 7:141,081,943...141,093,924
Ensembl chr 7:141,081,943...141,095,691
G
Ndrg1
N-myc downstream regulated 1
increases expression
ISO
ferric oxide analog results in increased expression of NDRG1 mRNA
CTD
PMID:25086211
NCBI chr 7:107,734,326...107,775,701
Ensembl chr 7:107,734,323...107,775,714
G
Nedd9
neural precursor cell expressed, developmentally down-regulated 9
increases expression
ISO
ferric oxide analog results in increased expression of NEDD9 mRNA
CTD
PMID:24525745
NCBI chr17:22,984,792...23,179,701
Ensembl chr17:22,984,844...23,179,701
G
Nox4
NADPH oxidase 4
increases expression
ISO
ferric oxide results in increased expression of NOX4 protein
CTD
PMID:28077287 PMID:28993115
NCBI chr 1:150,796,359...150,976,186
Ensembl chr 1:150,797,084...150,976,194
G
Npm3
nucleophosmin/nucleoplasmin, 3
decreases expression
ISO
ferric oxide analog results in decreased expression of NPM3 mRNA
CTD
PMID:25086211
NCBI chr 1:265,504,105...265,506,080
Ensembl chr 1:265,504,575...265,506,046
G
Nrp1
neuropilin 1
decreases expression
ISO
ferric oxide analog results in decreased expression of NRP1 mRNA
CTD
PMID:25086211
NCBI chr19:61,332,351...61,486,166
Ensembl chr19:61,332,351...61,485,858
G
Nt5c2
5'-nucleotidase, cytosolic II
increases expression
ISO
ferric oxide analog results in increased expression of NT5C2 mRNA
CTD
PMID:24525745
NCBI chr 1:266,652,966...266,782,935
Ensembl chr 1:266,659,519...266,782,910
G
Nupr1
nuclear protein 1, transcriptional regulator
decreases expression
ISO
ferric oxide analog results in decreased expression of NUPR1 mRNA
CTD
PMID:24525745
NCBI chr 1:194,767,484...194,769,519
Ensembl chr 1:194,767,474...194,769,524
G
Oas2
2'-5' oligoadenylate synthetase 2
decreases expression
ISO
ferric oxide analog results in decreased expression of OAS2 mRNA
CTD
PMID:25086211
NCBI chr12:41,341,417...41,363,124
Ensembl chr12:41,340,815...41,363,161
G
Oasl
2'-5'-oligoadenylate synthetase-like
decreases expression
ISO
ferric oxide analog results in decreased expression of OASL1 mRNA
CTD
PMID:25086211
NCBI chr12:47,444,138...47,456,680
Ensembl chr12:47,444,104...47,456,894
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage multiple interactions
ISO
ferric oxide analog results in increased cleavage of PARP1 protein ferric oxide results in decreased expression of and results in increased cleavage of PARP1 protein ferric oxide results in increased cleavage of PARP1 protein
CTD
PMID:26991130 PMID:27270449 PMID:28993115
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
G
Pate4
prostate and testis expressed 4
affects expression
ISO
ferric oxide affects the expression of PATE4 mRNA
CTD
PMID:28077287
NCBI chr 8:36,815,007...36,817,747
Ensembl chr 8:36,815,007...36,817,747
G
Pcdh7
protocadherin 7
decreases expression
ISO
ferric oxide analog results in decreased expression of PCDH7 mRNA
CTD
PMID:25086211
NCBI chr14:54,649,054...55,081,632
Ensembl chr14:55,072,200...55,081,551
G
Per2
period circadian regulator 2
increases expression
ISO
ferric oxide analog results in increased expression of PER2 mRNA
CTD
PMID:25086211
NCBI chr 9:98,555,154...98,597,362
Ensembl chr 9:98,555,169...98,597,359
G
Pes1
pescadillo ribosomal biogenesis factor 1
decreases expression
ISO
ferric oxide analog results in decreased expression of PES1 mRNA
CTD
PMID:25086211
NCBI chr14:84,211,600...84,227,980
Ensembl chr14:84,211,600...84,227,978
G
Phlda1
pleckstrin homology-like domain, family A, member 1
increases expression
ISO
ferric oxide analog results in increased expression of PHLDA1 mRNA
CTD
PMID:25086211
NCBI chr 7:54,247,460...54,249,664
Ensembl chr 7:54,247,460...54,249,664
G
Plekhf1
pleckstrin homology and FYVE domain containing 1
increases expression
ISO
ferric oxide analog results in increased expression of PLEKHF1 mRNA
CTD
PMID:25086211
NCBI chr 1:94,609,041...94,616,565
Ensembl chr 1:94,609,377...94,610,854
G
Plk2
polo-like kinase 2
increases expression
ISO
ferric oxide analog results in increased expression of PLK2 mRNA
CTD
PMID:25086211
NCBI chr 2:41,911,143...41,916,901
Ensembl chr 2:41,911,131...41,916,901
G
Plk3
polo-like kinase 3
increases expression
ISO
ferric oxide analog results in increased expression of PLK3 mRNA
CTD
PMID:25086211
NCBI chr 5:135,997,725...136,002,900
Ensembl chr 5:135,997,725...136,002,900
G
Plpbp
pyridoxal phosphate binding protein
increases expression
ISO
ferric oxide analog results in increased expression of PLPBP mRNA
CTD
PMID:25086211
NCBI chr16:69,164,654...69,176,245
Ensembl chr16:69,163,577...69,176,036
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
decreases expression
ISO
ferric oxide analog results in decreased expression of PPP1R15A mRNA
CTD
PMID:24525745
NCBI chr 1:101,511,899...101,515,043
Ensembl chr 1:101,511,901...101,514,974
G
Prf1
perforin 1
decreases expression
ISO
ferric oxide analog results in decreased expression of PRF1 mRNA
CTD
PMID:24525745
NCBI chr20:30,915,294...30,920,804
Ensembl chr20:30,915,213...30,921,382
G
Prmt6
protein arginine methyltransferase 6
decreases expression
ISO
ferric oxide analog results in decreased expression of PRMT6 mRNA
CTD
PMID:25086211
NCBI chr 2:213,173,403...213,180,721
Ensembl chr 2:213,173,403...213,178,632 Ensembl chr 2:213,173,403...213,178,632
G
Prr18
proline rich 18
increases expression
ISO
ferric oxide analog results in increased expression of PRR18 mRNA
CTD
PMID:25086211
NCBI chr 1:52,989,076...52,994,843
Ensembl chr 1:52,991,287...52,992,213
G
Prr33
proline rich 33
decreases expression
ISO
ferric oxide analog results in decreased expression of PRR33 mRNA
CTD
PMID:25086211
NCBI chr 1:215,658,996...215,666,512
Ensembl chr 1:215,659,713...215,660,492
G
Rab15
RAB15, member RAS oncogene family
increases expression
ISO
ferric oxide analog results in increased expression of RAB15 mRNA
CTD
PMID:25086211
NCBI chr 6:99,845,952...99,870,320
Ensembl chr 6:99,845,954...99,870,024
G
Rad50
RAD50 double strand break repair protein
decreases expression
ISO
ferric oxide analog results in decreased expression of RAD50 mRNA
CTD
PMID:24525745
NCBI chr10:39,002,130...39,054,042
Ensembl chr10:39,001,498...39,054,142
G
Rbak
RB-associated KRAB zinc finger
increases expression
ISO
ferric oxide analog results in increased expression of RBAK mRNA
CTD
PMID:24525745
NCBI chr12:13,428,648...13,442,279
Ensembl chr12:13,428,685...13,442,286
G
Rcan1
regulator of calcineurin 1
increases expression
ISO
ferric oxide analog results in increased expression of RCAN1 mRNA
CTD
PMID:25086211
NCBI chr11:32,539,689...32,620,274
Ensembl chr11:32,539,683...32,550,539
G
Rcbtb2
RCC1 and BTB domain containing protein 2
increases expression
ISO
ferric oxide analog results in increased expression of RCBTB2 mRNA
CTD
PMID:24525745
NCBI chr15:55,029,388...55,074,728
Ensembl chr15:55,034,033...55,073,437
G
Rilpl1
Rab interacting lysosomal protein-like 1
decreases expression
ISO
ferric oxide analog results in decreased expression of RILPL1 mRNA
CTD
PMID:24525745
NCBI chr12:37,490,320...37,528,393
Ensembl chr12:37,490,584...37,528,784
G
Ripk1
receptor interacting serine/threonine kinase 1
multiple interactions
EXP
[ferric oxide analog co-treated with Acrolein] results in increased expression of RIPK1 protein
CTD
PMID:24847785
NCBI chr17:31,537,580...31,569,904
Ensembl chr17:31,537,591...31,569,904
G
Ripk3
receptor-interacting serine-threonine kinase 3
multiple interactions
EXP
[ferric oxide analog co-treated with Acrolein] results in increased expression of RIPK3 protein
CTD
PMID:24847785
NCBI chr15:34,470,796...34,479,741
Ensembl chr15:34,470,796...34,479,741
G
RT1-Db1
RT1 class II, locus Db1
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with ferric oxide] results in increased expression of H2-EB1 mRNA
CTD
PMID:20540983
NCBI chr20:4,087,621...4,097,190
Ensembl chr20:4,087,618...4,097,190
G
RT1-S3
RT1 class Ib, locus S3
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with ferric oxide] results in increased expression of H2-T23 mRNA
CTD
PMID:20540983
NCBI chr20:3,176,124...3,180,825
Ensembl chr20:3,176,107...3,179,818
G
Rusc2
RUN and SH3 domain containing 2
increases expression
ISO
ferric oxide analog results in increased expression of RUSC2 mRNA
CTD
PMID:25086211
NCBI chr 5:58,860,444...58,883,152
Ensembl chr 5:58,855,773...58,882,096
G
Samd9
sterile alpha motif domain containing 9
decreases expression
ISO
ferric oxide analog results in decreased expression of SAMD9L mRNA
CTD
PMID:25086211
NCBI chr 4:28,304,967...28,324,637
Ensembl chr 4:28,305,002...28,310,178
G
Serpinb1a
serpin family B member 1A
decreases expression
ISO
ferric oxide analog results in decreased expression of SERPINB1A mRNA
CTD
PMID:24525745
NCBI chr17:32,903,089...32,911,498
Ensembl chr17:32,904,119...32,911,495
G
Skil
SKI-like proto-oncogene
increases expression
ISO
ferric oxide analog results in increased expression of SKIL mRNA
CTD
PMID:24525745
NCBI chr 2:115,862,932...115,891,304
Ensembl chr 2:115,866,701...115,891,097
G
Slamf8
SLAM family member 8
increases expression
ISO
ferric oxide analog results in increased expression of SLAMF8 mRNA
CTD
PMID:24525745
NCBI chr13:90,967,862...90,978,752
Ensembl chr13:90,967,739...90,977,734
G
Slc11a1
solute carrier family 11 member 1
increases expression
ISO
ferric oxide analog results in increased expression of SLC11A1 mRNA
CTD
PMID:25086211
NCBI chr 9:81,655,590...81,666,697
Ensembl chr 9:81,655,629...81,666,706
G
Slc46a3
solute carrier family 46, member 3
decreases expression
ISO
ferric oxide analog results in decreased expression of SLC46A3 mRNA
CTD
PMID:25086211
NCBI chr12:8,725,479...8,741,944
Ensembl chr12:8,725,517...8,741,951
G
Slpi
secretory leukocyte peptidase inhibitor
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with ferric oxide] results in increased expression of SLPI mRNA
CTD
PMID:20540983
NCBI chr 3:160,799,979...160,802,228
Ensembl chr 3:160,799,981...160,802,433
G
Sod1
superoxide dismutase 1
increases expression
ISO
ferric oxide analog results in increased expression of SOD1 protein
CTD
PMID:24068039
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
G
Sod2
superoxide dismutase 2
increases expression
ISO
ferric oxide analog results in increased expression of SOD2 protein; ferric oxide results in increased expression of SOD2 protein
CTD
PMID:24068039 PMID:25086211 PMID:26991130
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
G
Spata24
spermatogenesis associated 24
decreases expression
ISO
ferric oxide analog results in decreased expression of SPATA24 mRNA
CTD
PMID:24525745
NCBI chr18:28,446,592...28,454,724
Ensembl chr18:28,446,589...28,454,756
G
Tatdn2
TatD DNase domain containing 2
decreases expression
ISO
ferric oxide analog results in decreased expression of TATDN2 mRNA
CTD
PMID:24525745
NCBI chr 4:145,653,299...145,669,343
Ensembl chr 4:145,653,602...145,669,343
G
Tbc1d2
TBC1 domain family, member 2
increases expression decreases expression
ISO
ferric oxide analog results in increased expression of TBC1D2 mRNA ferric oxide analog results in decreased expression of TBC1D2 mRNA
CTD
PMID:24525745 PMID:25086211
NCBI chr 5:62,213,001...62,261,467
Ensembl chr 5:62,212,982...62,260,105
G
Tbxas1
thromboxane A synthase 1
increases expression
ISO
ferric oxide analog results in increased expression of TBXAS1 mRNA
CTD
PMID:24525745
NCBI chr 4:66,624,181...66,846,745
Ensembl chr 4:66,670,618...66,846,805
G
Tf
transferrin
increases expression
EXP
ferric oxide results in increased expression of TF mRNA
CTD
PMID:16428268
NCBI chr 8:111,694,570...111,721,275
Ensembl chr 8:111,673,547...111,721,333
G
Tfrc
transferrin receptor
decreases expression
ISO
ferric oxide analog results in decreased expression of TFRC mRNA
CTD
PMID:25086211
NCBI chr11:71,397,423...71,419,263
Ensembl chr11:71,397,383...71,419,223
G
Tgfbi
transforming growth factor, beta induced
increases expression
ISO
ferric oxide analog results in increased expression of TGFBI mRNA
CTD
PMID:24525745
NCBI chr17:8,400,123...8,429,338
Ensembl chr17:8,400,146...8,429,338
G
Tgm2
transglutaminase 2
increases expression
ISO
ferric oxide analog results in increased expression of TGM2 mRNA
CTD
PMID:25086211
NCBI chr 3:154,597,165...154,627,257
Ensembl chr 3:154,597,168...154,627,257
G
Timp1
TIMP metallopeptidase inhibitor 1
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with ferric oxide] results in increased expression of TIMP1 mRNA
CTD
PMID:20540983
NCBI chr X:1,364,771...1,369,451
Ensembl chr X:1,364,786...1,369,384
G
Timp2
TIMP metallopeptidase inhibitor 2
increases expression
ISO
ferric oxide results in increased expression of TIMP2 protein
CTD
PMID:24885771
NCBI chr10:107,338,465...107,386,072
Ensembl chr10:107,338,465...107,386,072
G
Tlr2
toll-like receptor 2
increases expression
ISO
ferric oxide analog results in increased expression of TLR2 mRNA
CTD
PMID:24525745
NCBI chr 2:182,840,171...182,846,061
Ensembl chr 2:182,840,727...182,846,061
G
Tmem176a
transmembrane protein 176A
decreases expression
ISO
ferric oxide analog results in decreased expression of TMEM176A mRNA
CTD
PMID:25086211
NCBI chr 4:78,458,735...78,462,415
Ensembl chr 4:78,458,625...78,462,423
G
Tnf
tumor necrosis factor
multiple interactions increases secretion
ISO
[Magnetite Nanoparticles co-treated with ferric oxide] results in increased expression of TNF protein ferric oxide results in increased secretion of TNF protein ferric oxide analog results in increased secretion of TNF protein
CTD
PMID:20540983 PMID:24068039 PMID:24525745 PMID:24885771
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
G
Tnni3
troponin I3, cardiac type
increases expression
ISO
ferric oxide results in increased expression of TNNI3 protein
CTD
PMID:28993115
NCBI chr 1:72,882,806...72,886,490
Ensembl chr 1:72,882,806...72,886,488
G
Tp53
tumor protein p53
increases phosphorylation multiple interactions
EXP
ferric oxide analog results in increased phosphorylation of TP53 protein [ferric oxide analog co-treated with Acrolein] results in increased expression of TP53 protein
CTD
PMID:22995439 PMID:24847785
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Tp53inp1
tumor protein p53 inducible nuclear protein 1
increases expression
ISO
ferric oxide analog results in increased expression of TRP53INP1 mRNA
CTD
PMID:25086211
NCBI chr 5:24,402,895...24,419,651
Ensembl chr 5:24,410,863...24,416,888
G
Tpr
translocated promoter region, nuclear basket protein
decreases expression
ISO
ferric oxide analog results in decreased expression of TPR mRNA
CTD
PMID:24525745
NCBI chr13:67,611,685...67,672,833
Ensembl chr13:67,611,708...67,672,827
G
Trib3
tribbles pseudokinase 3
decreases expression
ISO
ferric oxide analog results in decreased expression of TRIB3 mRNA
CTD
PMID:24525745
NCBI chr 3:147,814,056...147,819,650
Ensembl chr 3:147,813,473...147,819,571
G
Ttpal
alpha tocopherol transfer protein like
decreases expression
ISO
ferric oxide analog results in decreased expression of TTPAL mRNA
CTD
PMID:25086211
NCBI chr 3:159,995,013...160,015,314
Ensembl chr 3:159,995,064...160,013,274
G
Tubb2b
tubulin, beta 2B class IIb
increases expression
ISO
ferric oxide analog results in increased expression of TUBB2B mRNA
CTD
PMID:24525745
NCBI chr17:31,441,640...31,444,687
Ensembl chr17:31,441,630...31,482,759
G
Wdfy3
WD repeat and FYVE domain containing 3
increases expression
ISO
ferric oxide analog results in increased expression of WDFY3 mRNA
CTD
PMID:24525745
NCBI chr14:9,169,409...9,384,835
Ensembl chr14:9,141,512...9,381,870
G
Yipf7
Yip1 domain family, member 7
increases expression
ISO
ferric oxide analog results in increased expression of YIPF7 mRNA
CTD
PMID:25086211
NCBI chr14:62,565,369...62,609,529
Ensembl chr14:62,567,745...62,595,854
G
Zbtb2
zinc finger and BTB domain containing 2
decreases expression
ISO
ferric oxide analog results in decreased expression of ZBTB2 mRNA
CTD
PMID:24525745
NCBI chr 1:40,914,175...40,933,586
Ensembl chr 1:40,914,171...40,921,508
G
Zc3h13
zinc finger CCCH type containing 13
increases expression
ISO
ferric oxide analog results in increased expression of ZC3H13 mRNA
CTD
PMID:24525745
NCBI chr15:57,340,522...57,405,287
Ensembl chr15:57,340,579...57,405,287
G
Zfp36
zinc finger protein 36
increases expression
ISO
ferric oxide analog results in increased expression of ZFP36 mRNA
CTD
PMID:24525745
NCBI chr 1:85,380,088...85,382,565
Ensembl chr 1:85,380,088...85,382,569
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
[Ferrosoferric Oxide binds to titanium dioxide] which results in increased expression of BAX protein
CTD
PMID:30098274
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
ISO
[Ferrosoferric Oxide binds to titanium dioxide] which results in decreased expression of BCL2 protein
CTD
PMID:30098274
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
G
Casp3
caspase 3
multiple interactions
ISO
[Ferrosoferric Oxide binds to titanium dioxide] which results in increased cleavage of CASP3 protein; [Methotrexate co-treated with [Ferrosoferric Oxide binds to polylactide-polyethylene glycol-polylactide]] results in increased expression of CASP3 mRNA; [Methotrexate co-treated with [Ferrosoferric Oxide binds to polylactide-polyethylene glycol-polylactide]] results in increased expression of CASP3 protein modified form
CTD
PMID:24935781 PMID:30098274
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
G
Casp9
caspase 9
multiple interactions
ISO
[Ferrosoferric Oxide binds to titanium dioxide] which results in increased cleavage of CASP9 protein
CTD
PMID:30098274
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
G
Fadd
Fas associated via death domain
multiple interactions
ISO
[Ferrosoferric Oxide binds to titanium dioxide] which results in decreased expression of FADD protein
CTD
PMID:30098274
NCBI chr 1:217,746,176...217,748,581
Ensembl chr 1:217,742,929...217,748,628
G
Fas
Fas cell surface death receptor
multiple interactions
ISO
[Ferrosoferric Oxide binds to titanium dioxide] which results in increased expression of FAS protein
CTD
PMID:30098274
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
[Ferrosoferric Oxide binds to titanium dioxide] which results in increased expression of FOS protein
CTD
PMID:30098274
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
[Ferrosoferric Oxide binds to titanium dioxide] which results in decreased expression of HMOX1 protein
CTD
PMID:30098274
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
G
Il1b
interleukin 1 beta
increases secretion
EXP ISO
Ferrosoferric Oxide analog results in increased secretion of IL1B protein Ferrosoferric Oxide results in increased secretion of IL1B protein
CTD
PMID:22939914 PMID:24885771
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
G
Il6
interleukin 6
increases secretion
EXP ISO
Ferrosoferric Oxide analog results in increased secretion of IL6 protein Ferrosoferric Oxide results in increased secretion of IL6 protein
CTD
PMID:22939914 PMID:24885771
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
[Ferrosoferric Oxide binds to titanium dioxide] which results in increased expression of JUN protein
CTD
PMID:30098274
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
[Ferrosoferric Oxide binds to titanium dioxide] which results in increased phosphorylation of MAPK1 protein
CTD
PMID:30098274
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
[Ferrosoferric Oxide binds to titanium dioxide] which results in increased phosphorylation of MAPK3 protein
CTD
PMID:30098274
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
ISO
[Ferrosoferric Oxide binds to titanium dioxide] which results in increased phosphorylation of MAPK8 protein
CTD
PMID:30098274
NCBI chr16:9,620,854...9,709,342
Ensembl chr16:9,625,177...9,709,347
G
Mapk9
mitogen-activated protein kinase 9
multiple interactions
ISO
[Ferrosoferric Oxide binds to titanium dioxide] which results in increased phosphorylation of MAPK9 protein
CTD
PMID:30098274
NCBI chr10:35,333,859...35,374,364
Ensembl chr10:35,333,859...35,374,355
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
ISO
[Ferrosoferric Oxide binds to titanium dioxide] which results in increased expression of NQO1 protein
CTD
PMID:30098274
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
[Ferrosoferric Oxide binds to titanium dioxide] which results in decreased expression of PARP1 protein
CTD
PMID:30098274
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
[Ferrosoferric Oxide binds to titanium dioxide] which results in increased expression of PTGS2 protein
CTD
PMID:30098274
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
G
Rras
RAS related
multiple interactions
ISO
[Ferrosoferric Oxide binds to titanium dioxide] which results in increased expression of RRAS protein
CTD
PMID:30098274
NCBI chr 1:101,012,822...101,016,720
Ensembl chr 1:101,012,822...101,016,720
G
Tnf
tumor necrosis factor
increases secretion
EXP
Ferrosoferric Oxide analog results in increased secretion of TNF protein
CTD
PMID:22939914
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
G
Tp53
tumor protein p53
multiple interactions
ISO
[Ferrosoferric Oxide binds to titanium dioxide] which results in increased expression of TP53 protein
CTD
PMID:30098274
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
bromotetrandrine promotes the reaction [[ferric oxide co-treated with ferrous oxide co-treated with Daunorubicin] results in increased expression of BAX protein]
CTD
PMID:19421372
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
G
Casp3
caspase 3
multiple interactions
ISO
bromotetrandrine promotes the reaction [[ferric oxide co-treated with ferrous oxide co-treated with Daunorubicin] results in increased expression of CASP3 protein]
CTD
PMID:19421372
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
G
Icam1
intercellular adhesion molecule 1
increases expression
ISO
ferrous oxide results in increased expression of ICAM1 protein
CTD
PMID:21439359
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all